NCT06628908ClinicalTrials.gov
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
בקצרה
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
שלב 3דרושים 1,100 משתתפים76 אתריםמדינה אחת
קטגוריות
רשום במרשם אחד
- ClinicalTrials.govNCT06628908פתיחת רשומה זו ב־ClinicalTrials.govסונכרן לפני חודשיים
מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.
מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.
מתעניינים במחקר הזה?
התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 7 days after the recorded start)First posted 2024-10-08; recorded start 2024-10-01
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 92 other studies in this databaseCounted from the lead sponsor named in the record (Vertex Pharmaceuticals Incorporated)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
- Intervention regulatory context: investigational, within a phased regulatory pathway.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A definitive-grade design for a phase 3 study, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding20/20
Quadruple-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre8/8
Multi-centre: 76 sites
- Data monitoring committee0/7
Data monitoring committee not stated in the record
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,100 participants (target), run at 76 sites.
How this score is built
- Enrolment30/40
1,100 participants (target)
- Site count22/25
76 sites
- Country count0/15
Single country
- Planned duration8/10
Planned over about 32 months
- Sponsor scale7/10
Vertex Pharmaceuticals Incorporated has led 90 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
תקציר
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
מצבים רפואיים
- Diabetic Peripheral Neuropathic Pain
זכאות
| מין | הכול |
|---|---|
| גילאים | 18 Years – 80 Years |
| מתנדבים בריאים | לא |
זכאות כפי שנכתבה במרשם
זכאות במשפטים פשוטים
הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.
תכנון המחקר
| סוג המחקר | התערבותי |
|---|---|
| שלב | שלב 3 |
| הקצאה | אקראי |
| מודל ההתערבות | PARALLEL |
| מטרה ראשית | TREATMENT |
| הסתרה | QUADRUPLE (4) |
| גיוס | דרושים 1,100 משתתפים |
נותן חסות ושותפים
- Vertex Pharmaceuticals Incorporated נותן חסות
זרועות והתערבויות
- Suzetrigine (SUZ)EXPERIMENTAL
Participants will be randomized to receive SUZ.
- PregabalinACTIVE_COMPARATOR
Participants will be randomized to receive Pregabalin.
- PlaceboPLACEBO_COMPARATOR
Participants will be randomized to receive placebo matched to SUZ and Pregabalin.
התערבויות
- תרופה Placebo (matched to Pregabalin)
Placebo matched to Pregabalin for oral administration.
- תרופה Placebo (matched to SUZ)
Placebo matched to SUZ for oral administration.
- תרופה Pregabalin
Capsules for oral administration.
- תרופה Suzetrigine
Tablets for oral administration.
מדדי תוצאה
מדד תוצאה ראשוני
Change From Baseline in the Weekly Average of Daily Pain Intensity on the Numeric Pain Rating Scale (NPRS) at Week 12 Compared to Placebo
מסגרת זמן From Baseline up to Week 12
מדד תוצאה משני
Change From Baseline in the Medical Outcomes Study 36-item Short-form Health Status (SF 36v2) Physical Component Summary (PCS) Score at Week 12 Compared to Placebo (pooled with data from Study VX24-548-111)
מסגרת זמן From Baseline up to Week 12
מדד תוצאה משני
Change From Baseline in the Weekly Average of Daily Pain Intensity on the NPRS at Week 12 Compared to Pregabalin
מסגרת זמן From Baseline up to Week 12
תאריכים
| תאריך התחלה | 1 באוקטובר 2024 (בפועל) |
|---|---|
| סיום ראשוני | 31 במאי 2027 (משוער) |
| סיום | 31 במאי 2027 (משוער) |
| פורסם לראשונה | 8 באוקטובר 2024 (בפועל) |
| עודכן לאחרונה | 15 ביוני 2026 |
| התוצאות פורסמו | לא צוין ברשומת המרשם |
| המצב אומת לאחרונה | יוני 2026 |
בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.
מיקומים
59 אתרים מגייסים
United States
| מתקן | עיר | מדינה או אזור | מצב |
|---|---|---|---|
| Albany Medical College | Albany | New York | הושלם |
| Velocity Clinical Research - Albuquerque | Albuquerque | New Mexico | מגייס |
| Synexus Clinical Research- Anderson | Anderson | South Carolina | הושלם |
| Pinnacle Research Group, LLC | Anniston | Alabama | מגייס |
| Velocity Clinical Research - Baton Rouge | Baton Rouge | Louisiana | מגייס |
| Velocity Clinical Research - Cleveland | Beachwood | Ohio | מגייס |
| Northwest Clinical Research Center (NWCRC) | Bellevue | Washington | מגייס |
| Synexus Clinical Research - Birmingham | Birmingham | Alabama | הושלם |
| Mass General Brigham - Brigham and Women's Hospital - Main Campus | Boston | Massachusetts | מגייס |
| Swift Clinical OpCo, Inc | Brooklyn | New York | מגייס |
| Clinical Trials of South Carolina - Berkeley - Charleston | Charleston | South Carolina | מגייס |
| M3 Wake Research - Charleston | Charleston | South Carolina | מגייס |
| Feinberg School of Medicine - Anesthesiology | Chicago | Illinois | מגייס |
| Synexus Clinical Research - Cincinnati | Cincinnati | Ohio | הושלם |
| Tandem Clinical Research- Covington | Covington | Louisiana | מגייס |
| Synexus Clinical Research - Dallas (DFW) (DRS) | Dallas | Texas | הושלם |
| Zenos Clinical Research | Dallas | Texas | מגייס |
| AMR Daphne, AL | Daphne | Alabama | הושלם |
| META Medical Research Institute | Dayton | Ohio | מגייס |
| Accel Research - Deland | DeLand | Florida | מגייס |
| Accel Research - Decatur | Decatur | Georgia | מגייס |
| AMR-Miami | Doral | Florida | מגייס |
| Velocity Clinical Research - Providence | East Greenwich | Rhode Island | מגייס |
| Velocity Clinical Research - Syracuse | East Syracuse | New York | מגייס |
| Velocity Clinical Research - Denver | Englewood | Colorado | מגייס |
| Synexus Clinical Research - Evansville | Evansville | Indiana | הושלם |
| Healthcare Research Network - Flossmoor IL | Flossmoor | Illinois | מגייס |
| AMR Fort Myers (The Clinical Study Center) | Fort Myers | Florida | מגייס |
| Neuro-Pain Medical Center | Fresno | California | מגייס |
| Velocity Clinical Research - Grants Pass | Grants Pass | Oregon | הושלם |
| Velocity Clinical Research - Hallandale Beach | Hallandale | Florida | מגייס |
| Healthcare Research Network - Hazelwood MO | Hazelwood | Missouri | מגייס |
| CNS Healthcare - Jacksonville | Jacksonville | Florida | מגייס |
| AMR Kansas City | Kansas City | Missouri | מגייס |
| Accel Research - St. Petersburg-Largo | Largo | Florida | מגייס |
| Synexus Clinical Research - Las Vegas | Las Vegas | Nevada | הושלם |
| AMR Lexington | Lexington | Kentucky | מגייס |
| Long Beach Research Institute | Long Beach | California | מגייס |
| Angel City Research, Inc | Los Angeles | California | מגייס |
| Accel Research - Maitland | Maitland | Florida | הושלם |
| HRI - Hassman Research Institute | Marlton | New Jersey | הושלם |
| Velocity Clinical Research - Medford | Medford | Oregon | מגייס |
| Suburban Research Associates - Media | Media | Pennsylvania | מגייס |
| Velocity Clinical Research - Boise | Meridian | Idaho | מגייס |
| Suncoast Research Associates - Miami | Miami | Florida | מגייס |
| 3Sync Research - Miami Lakes | Miami Lakes | Florida | מגייס |
| West Clinical Research | Morehead City | North Carolina | מגייס |
| AMR Nashville, TN | Nashville | Tennessee | הושלם |
| Suncoast Clinical Research - New Port Richey | New Port Richey | Florida | מגייס |
| Columbia Presbyterian - The Neurological Institute of New York | New York | New York | מגייס |
26 אתרים נוספים מצוינים ברשומת המרשם.
מסמכי המחקר
לא צורפו מסמכים ברשומת מרשם זו.
שינויים לאורך זמן
לא נרשמו שינויים מאז שקלטנו רשומה זו לראשונה.
שינוי נרשם בכל פעם שנותן החסות מעדכן את רשומת המרשם. מצב, תאריכים, גיוס ואתרים מופיעים כאן ככל שהם משתנים.